Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study

OBJECTIVE: The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. METHODS: This was a phase II, randomized, placebo-controlled parallel group study conducted at 37 US centers...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endometr Pelvic Pain Disord
Autori principali: Carr, Bruce, Giudice, Linda, Dmowski, W. Paul, O'Brien, Chris, Jiang, Ping, Burke, Joshua, Jimenez, Roland, Hass, Steven, Fuldeore, Mahesh, Chwalisz, Kristof
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2013
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166402/
https://ncbi.nlm.nih.gov/pubmed/30320043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5301/je.5000157
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi